BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lechanska‐helman J, Sobocinska A, Jerzynska J, Stelmach I. The influence of hospital‐based intravenous immunoglobulin and home‐based self‐administrated subcutaneous immunoglobulin therapy in young children with primary immunodeficiency diseases on their parents’ / caregivers’ satisfaction. Pediatrics International 2020;62:316-8. [DOI: 10.1111/ped.14119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Anderson JT, Cowan J, Condino-neto A, Levy D, Prusty S. Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ayaz NA, Karadağ ŞG, Koç R, Demirkan FG, Çakmak F, Sönmez HE. Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study. Rheumatol Int 2020;40:1111-6. [PMID: 32417938 DOI: 10.1007/s00296-020-04596-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]